Trial
NCT03784443
Combined Ranibizumab and Iluvien for Diabetic Macular Oedema
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Imperial College London
Collaborators
—
Condition
Diabetic Macular Edema
Intervention
Iluvien 0.19 MG Drug Implant
Why stopped
Funder withdrawn funding.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-10-02